IHS Chemical Week

Regions :: Western Europe :: U.K.

Reckitt Benckiser continuing to review pharma options

1:51 AM MST | February 12, 2014 | Natasha Alperowicz

Consumer goods group Reckitt Benckiser (Slough, UK) today announced its quarterly and annual results and said that it is still reviewing the future of its pharmaceuticals business. Fourth-quarter sales were 5% higher at constant exchange rates, at £2.5 billion ($4.1 billion). Quarterly profits have not been disclosed. Full-year 2013 net income was down 5%, to £1.74 billion, on 5% higher sales, at £10 billion. “Our strategy for growth and outperformance through driving health and hygiene power brands together with our focus on 16 power...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa